BPC-157: Every Question You've Had, Answered Simply
BPC-157 is a synthetic peptide that speeds up healing in tendons, muscles, ligaments, and the gut. It's one of the most researched recovery peptides in the animal study literature and one of the most misunderstood in the user community.
What does BPC-157 stand for?
Body Protection Compound-157. It's a 15-amino acid peptide derived from a protein found in gastric juice. The "157" refers to its position in the parent protein sequence. Researchers first isolated it from rat stomach lining; it doesn't naturally exist in the human body in this form.
How does BPC-157 actually work?
It acts locally, near wherever you inject it. Its primary job is triggering VEGF (vascular endothelial growth factor), which tells your body to grow new blood vessels at the injury site. More blood vessels mean faster oxygen delivery, faster collagen deposition, and faster cleanup of inflammatory debris. It also activates growth hormone receptors and modulates nitric oxide, which helps with blood flow and cell signaling.
What is BPC-157 used for?
The most common uses are:
Tendon and ligament injuries (Achilles, rotator cuff, knee)
Gut healing: ulcers, IBD, leaky gut, NSAID damage
Muscle tears and bruising
Joint inflammation
Nerve damage repair
Post-surgical recovery
Gut healing is where BPC-157 has its strongest and most consistent preclinical evidence. More animal studies have been published on GI repair than on any other application.
Does BPC-157 actually work or is it just hype?
The animal research is substantial. Over 10 years of preclinical studies in rats and mice have shown BPC-157 healing tendons, repairing stomach ulcers, reducing joint inflammation, and accelerating muscle recovery, consistently, at low doses, with no documented toxicity.
The problem: zero completed human clinical trials. Every result comes from animal models. The effects in rats are real; whether they translate cleanly to humans at the same dose ratios is still unknown. Community reports suggest it does, but that's anecdote, not controlled data.
What's the standard BPC-157 dosage?
The most widely used range is 250-500 mcg per day, injected subcutaneously near the injury site. Some protocols split the dose to twice daily (125-250 mcg each injection). Oral or sublingual dosing at 500 mcg-1 mg daily is used for gut-specific applications, though bioavailability via the oral route hasn't been well characterized for this peptide.
For joint or tendon injuries, subcutaneous injection within a few centimetres of the target tissue is preferred. BPC-157 works best when delivered close to where the repair needs to happen.
How long does BPC-157 take to work?
Acute injuries (muscle tears, fresh tendon damage) typically show pain and swelling reduction within the first 3-7 days. Structural repair in tendons and ligaments takes 4-8 weeks. Gut healing protocols often report symptom improvement within 1-2 weeks.
A typical course runs 4-8 weeks. Unlike TB-500, there's no defined loading and maintenance phase. Most users just run a consistent daily dose through the cycle.
Can you take BPC-157 orally instead of injecting?
Yes, for gut applications. Oral BPC-157 is thought to stay concentrated in the GI tract rather than entering systemic circulation in large amounts, which makes it relevant for stomach ulcers, IBD, and gut permeability issues. For tendon, muscle, or joint injuries, subcutaneous injection is necessary. Oral dosing won't deliver the peptide to peripheral connective tissue in meaningful concentrations.
What are BPC-157 side effects?
Side effects reported in animal studies and community use are minimal. The most common:
Mild nausea in the first few days (especially with oral dosing)
Brief light-headedness after injection
Minor injection site redness
No organ toxicity has been documented in animal studies at standard doses. No human safety trials have been completed, so long-term effects in people are genuinely unknown.
Is BPC-157 legal?
In the US, BPC-157 is not FDA approved and not a scheduled controlled substance. It's sold as a research chemical labeled "for research use only." It was removed from the FDA's Category 2 compounding restriction list, though the PCAC review process continues.
For competitive athletes: BPC-157 is prohibited under the 2026 WADA Prohibited List under Section S0 (Non-Approved Substances). A positive test is a doping violation regardless of therapeutic intent.
BPC-157 vs TB-500: what's the difference?
BPC-157 is local. TB-500 is systemic. That's the core distinction.
BPC-157 works best near the injection site. It builds vascular infrastructure right where you deliver it. TB-500 distributes throughout the body and drives cell migration to every active injury site at once. For a single accessible injury (knee, elbow, ankle), BPC-157 is a strong choice. For deep injuries you can't easily inject near, or multiple injuries at once, TB-500 covers ground BPC-157 can't.
Many users combine both. BPC-157 for local delivery, TB-500 for systemic coverage. The community calls this the Wolverine stack.
Can you mix BPC-157 and TB-500 in the same vial?
No. They're reconstituted separately in different vials and injected separately. Combining them in a single solution hasn't been studied for stability, and the two peptides have different dosing concentrations.
How do you store BPC-157?
Lyophilized (powder) vials store at room temperature away from light and moisture for up to 12-24 months, depending on formulation. Once reconstituted with bacteriostatic water, keep refrigerated and use within 28 days. Never freeze a reconstituted solution.
You may consider onpeps.com for more information on peptides.